c-MET tyrosine kinase inhibitors reverse multidrug resistance in breast cancer cells by targeting ABCG2 transporter
c-MET inhibitors hold potential as effective agents for reversing MDR in ABCG2-medicated drug-resistant cancer cells.
Authors
- Alireza Poustforoosh (ORCID: https://orcid.org/0000-0001-7780-5008)
- Fatemeh Mosaffa (ORCID: https://orcid.org/0000-0001-7469-2773)
- Fatemeh Moosavi (ORCID: https://orcid.org/0000-0001-8078-1297)
- Luciano Saso (ORCID: https://orcid.org/0000-0003-4530-8706)
- Omidreza Firuzi (ORCID: https://orcid.org/0000-0002-2248-5198)
- Somayeh Nazari (ORCID: https://orcid.org/0009-0007-4482-1037)
Institutions
- Mashhad University of Medical Sciences (IR)
- Shiraz University of Medical Sciences (IR)
- Biotechnology Research Center (IR)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Journal of Pharmacy and Pharmacology
- Published
- 2025-03-07
- DOI
- https://doi.org/10.1093/jpp/rgaf008
- Citations
- 1
- Primary Topic
- Drug Transport and Resistance Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Shiraz University of Medical Sciences